The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 31, 2018
Filed:
Sep. 10, 2015
Applicant:
Sumitomo Dainippon Pharma Co., Ltd., Osaka-shi, JP;
Inventors:
Yasushi Ochiai, Osaka, JP;
Yuka Kato, Osaka, JP;
Maki Sasaki, Tokyo, JP;
Takafumi Matsumoto, Osaka, JP;
Assignee:
Sumitomo Dainippon Pharma Co., Ltd., Osaka-shi, JP;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/49 (2006.01); A61K 31/499 (2006.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/499 (2013.01); A61K 9/0048 (2013.01); A61K 9/10 (2013.01);
Abstract
The present invention relates to a stable ophthalmic suspension formulation comprising (R)-(−)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine-1,2′,3,5′-tetrone, which is useful for treating a disease in posterior eye segment and the like, avoiding side-effects due to systemic exposure.